Thermo Fisher Scientific (TMO) Announces Fiscal Q1 2026 Results

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best stem cell therapy stocks to buy. On April 23, Thermo Fisher Scientific Inc. (NYSE:TMO) announced financial results for fiscal Q1 2026. Revenue for the quarter rose 6% to $11.01 billion, compared to $10.36 billion in the same quarter last year. Organic revenue underwent a 1% growth. Management further reported that the GAAP diluted EPS in fiscal Q1 2026 was $4.43, reflecting an 11% growth compared to the prior year period. GAAP operating income for the quarter reached $1.86 billion, up 9% versus the year-ago quarter, while GAAP operating margin was 16.9%, compared with 16.6% in fiscal Q1 2025.

BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View

Thermo Fisher Scientific Inc. (NYSE:TMO) also stated that it advanced its proven growth strategy, launching a range of high-impact and innovative products during the quarter. This included a Thermo Scientific™ Glacios™ 3 Cryo-TEM, the Thermo Scientific™ TSQ Certis™ triple quadrupole mass spectrometer, the Thermo Scientific™ Niton™ XL5e Handheld XRF Analyzer, and the Gibco™ CTS™ Compleo™ Fill and Finish System.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments.

While we acknowledge the risk and potential of TMO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TMO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.